ArticleNPJ breast cancer2026

Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer.

Jesús Velasco-Suelto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.